Elham Beyranvand Nejad

4PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 08, 2022
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection.

Iris N Pardieck, Tetje C van der Sluis, Esmé T I van der Gracht

|Apr 21, 2021
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors.

Elham Beyranvand Nejad, Camilla Labrie, Marit J van Elsas

|Sep 03, 2020
Interleukin-6-mediated resistance to immunotherapy is linked to impaired myeloid cell function.

Elham Beyranvand Nejad, Camilla Labrie, Tetje C van der Sluis

|Sep 03, 2020
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy.

Elham Beyranvand Nejad, Camilla Labrie, Ziena Abdulrahman

Pageof 1